Skip to content

PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces Proposed Public Offering of Common Stock
PLAINSBORO, N.J. , May 09, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ:IART), a leading global medical technology company, today announced that it intends to offer, subject to market conditions and other factors, 5,250,000 shares of its common stock in an
View HTML
PDF Version
Toggle Summary Integra LifeSciences Announces Amendment and Extension of Credit Facility
PLAINSBORO, N.J. , May 07, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it has amended and extended its credit facility with a bank group led by Bank of America, N.A.
View HTML
PDF Version
Toggle Summary Integra LifeSciences to Present at Healthcare Conference in May 2018
PLAINSBORO, N.J. , April 26, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will present at the following healthcare conferences in May: On Tuesday, May 15, 2018 at 10:40 a.m.
View HTML
PDF Version
Toggle Summary Integra LifeSciences Debuts Codman Specialty Surgical Extended Portfolio at AANS 2018
PLAINSBORO, N.J., April 26, 2018 – Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, will be featuring its extended Codman Specialty Surgical product portfolio at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting,
View HTML
PDF Version
Toggle Summary Integra LifeSciences Reports First Quarter 2018 Financial Results
Revenue Increased 38.1% to $357.1 million ; Organic Revenue Increased 3.0%  Reported EPS of $0.14 ; Adjusted EPS of $0.58 Company Raises Full-Year Total Revenue and EPS Guidance PLAINSBORO, N.J. , April 25, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (NASDAQ:IART), a leading
View HTML
PDF Version
Toggle Summary Integra LifeSciences to Host First Quarter 2018 Earnings Results Conference Call on April 25, 2018
PLAINSBORO, N.J. , April 11, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release first quarter 2018 financial results on Wednesday, April 25, 2018 , prior to market open.
View HTML
PDF Version
Toggle Summary Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
The company reported 2017 fourth quarter revenue of $368.6 million, GAAP earnings per diluted share of $0.56 and adjusted earnings per diluted share of $0.64, ahead of preliminary results announced on January 8, 2018.
View HTML
Toggle Summary Integra LifeSciences Appoints Sravan Emany as Vice President, Treasurer and Investor Relations
PLAINSBORO, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Sravan Emany as vice president, treasurer and investor relations.  Mr. Emany will be a member of the Integra executive leadership team.
View HTML
Toggle Summary Integra LifeSciences to Present at Healthcare Conferences in March 2018
PLAINSBORO, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will present at the following healthcare conferences in March: On Monday, March 5, 2018 at 4:35 p.m.
View HTML
Toggle Summary Integra LifeSciences to Host Fourth Quarter 2017 Earnings Results Conference Call on February 27, 2018
PLAINSBORO, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release fourth quarter and full year 2017 financial results on Tuesday, February 27, 2018, prior to market open.
View HTML
Toggle Summary Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Results
Preliminary Fourth Quarter Highlights: Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the company's previous implied guidance range of $345 million to $355 million; Organic revenue growth in the fourth quarter is expected to be about
View HTML
Toggle Summary Integra LifeSciences to Present at the 36th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced President and Chief Executive Officer Peter Arduini will speak at the 36 th Annual J.P.
View HTML
Toggle Summary Integra LifeSciences Hosts Investor Day 2017 New York City
PLAINSBORO, N.J., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today will host an Investor Day meeting with analysts and institutional investors in New York City, beginning at 8:00 a.m. EST.
View HTML
Toggle Summary Integra LifeSciences Reports Third Quarter 2017 Financial Results
Revenue Increased 11.4% to $279 million; Organic Revenue Increased 1.5%  Reported EPS of $0.04; Adjusted EPS of $0.45 PLAINSBORO, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported financial
View HTML
Toggle Summary Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference Call on October 26, 2017
PLAINSBORO, N.J., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release 2017 third quarter financial results on Thursday, October 26, 2017, prior to market open.
View HTML